During the past decade, Sociedad Argentina de Reumatología conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sociedad Argentina de Reumatología" are "Rheumatic Diseases" (2 trials). Many other conditions were trialed in "Sociedad Argentina de Reumatología" in a lesser frequency.

Most popular intervention types in "Sociedad Argentina de Reumatología" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "COVID-19 Vaccine" (1 trials) and "Immunosuppressive Agents" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sociedad Argentina de Reumatología" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sociedad Argentina de Reumatología". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Sociedad Argentina de Reumatología, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sociedad Argentina de Reumatología, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".